Xinyan Xu, MD

MD Anderson Cancer Center
Houston, TX

Disclosures:

• Employment: The University of Texas MD Anderson Cancer Center:Research Assistant:Employee
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 1038 - Final Report of a Phase I/II Study of BMS-986156 (Glucocorticoid-Induced TNFR-Related Gene [GITR] Agonist) with Ipilimumab or Nivolumab with/without Stereotactic Ablative Radiotherapy in Patients with

  Tuesday, October 1, 2024
  8:15 AM – 8:20 AM ET